Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | +2.15% | -4.68% | -51.28% |
Sales 2024 * | 61.1M 4.89B | Sales 2025 * | 85.1M 6.81B | Capitalization | 139M 11.12B |
---|---|---|---|---|---|
Net income 2024 * | -26M -2.08B | Net income 2025 * | -19M -1.52B | EV / Sales 2024 * | 2 x |
Net cash position 2024 * | 16.87M 1.35B | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.63 x |
P/E ratio 2024 * |
-5.48
x | P/E ratio 2025 * |
-7.57
x | Employees | 1,430 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.84% |
Latest transcript on Augmedix, Inc.
1 day | +2.15% | ||
1 week | -4.68% | ||
Current month | -30.32% | ||
1 month | -27.20% | ||
3 months | -38.18% | ||
6 months | -37.09% | ||
Current year | -51.28% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Shakil
FOU | Founder | 40 | 31/12/11 |
Chief Executive Officer | 65 | 31/05/18 | |
Paul Ginocchio
DFI | Director of Finance/CFO | 55 | 30/06/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Laurie McGraw
BRD | Director/Board Member | 60 | 08/03/22 |
Margie Traylor
BRD | Director/Board Member | 60 | 30/04/21 |
Robert Faulkner
BRD | Director/Board Member | 61 | 09/04/23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.52% | 4 M€ | -5.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 2.85 | +2.15% | 320,653 |
25/04/24 | 2.79 | -2.11% | 244,808 |
24/04/24 | 2.85 | +0.35% | 263,740 |
23/04/24 | 2.84 | -5.02% | 141,061 |
22/04/24 | 2.99 | 0.00% | 182,445 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.28% | 139M | |
+10.55% | 67.6B | |
+11.64% | 18.21B | |
+21.03% | 13.41B | |
+9.40% | 13.37B | |
+16.53% | 9.94B | |
-32.90% | 5.74B | |
-10.98% | 5.57B | |
-4.09% | 4.91B | |
-4.83% | 4.87B |
- Stock Market
- Equities
- AUGX Stock